Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003313 |
---|---|
Receipt number | R000003989 |
Scientific Title | Multicenter Phase II study of erlotinib for advanced or recurrent non-small cell lung cancer with Epidermal Growth factor Receptor (EGFR) mutation (TORG0911) |
Date of disclosure of the study information | 2010/03/14 |
Last modified on | 2019/02/25 10:02:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/03/11 12:36:52 | ||
2 | Update | 2010/05/19 10:32:08 | Public title Public title Acronym Acronym |
|
3 | Update | 2010/05/19 10:33:15 | Recruitment status |
|
4 | Update | 2012/03/13 11:18:28 | Name of person sending information Organization Division name Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2013/08/02 13:50:35 | Recruitment status |
|
6 | Update | 2014/04/21 10:48:21 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL |
|
7 | Update | 2014/07/18 10:53:07 | Email |
|
8 | Update | 2014/12/03 13:18:52 | Recruitment status |
|
9 | Update | 2015/11/16 12:48:07 | Publication of results URL related to results and publications |
|
10 | Update | 2016/05/19 13:49:53 | Recruitment status |
|
11 | Update | 2016/05/19 13:50:38 | Name of primary person or sponsor Organization Category of Funding Organization |
|
12 | Update | 2019/02/25 10:02:50 | Recruitment status |